# Omlonti

NDC: 84826-002
Generic name: omidenepag isopropyl
Labeler / Manufacturer: Ocuvex Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20220923

FDA application: NDA215092

## Active ingredients

- OMIDENEPAG ISOPROPYL: .02 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84826-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84826-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4258e437-7e92-4b09-baf1-01cb158cfc05